GHO Capital is buying NaviMed’s Velocity Clinical Research, Clearlake creates series of single-asset pools to extend holds

GHO Capital is buying Velocity Clinical Research and Clearlake extends holds with fund series.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this